Assessing Clinicopathological Features and Prognosis of Triple-Negative Breast Cancer Patients: A Single-Center Study in Turkey
Background: Triple-negative breast cancer (TNBC) is defined as tumors without estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression. This cancer is associated with higher rates of recurrence risk when compared to other subtypes of breast...
Guardado en:
Autores principales: | Saliha Karagöz Eren, Alaettin Arslan, Ebru Akay, Nail Özhan, Yunus Dönder |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Kaviani Breast Disease Institute
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eb9d9b42722f4d538820570a9985b0bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Bingqing Xia, et al.
Publicado: (2021) -
The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer
por: Qianxue Wu, et al.
Publicado: (2021) -
Prognostic and clinicopathological values of tissue expression of MFAP5 and ITM2A in triple-negative breast cancer: an immunohistochemical study
por: Abdulwahab Abuderman, et al.
Publicado: (2020) -
Effect of Clinical and Treatment Factors on Survival Outcomes of Triple Negative Breast Cancer Patients
por: Wen S, et al.
Publicado: (2020) -
Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
por: Jesse Lopes da Silva, et al.
Publicado: (2021)